RxDoctor Payments Data

Yi Mao

Neurology · Spokane, WANPI 1629327986

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Route 92 Medical, Inc. at 35.8% of the total.

$1,365in general payments, 2019–2025

Across 9 payments — averaging $151.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Route 92 Medical, Inc.$488
  • Medtronic$301
  • Johnson & Johnson$248
  • Penumbra, Inc.$136
  • Microtransponder, Inc.$109
  • Imperative Care, Inc$84
$96,791in research payments, 2019–2025

Across 23 payments — averaging $4208.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$97K

What the payments were for

  • Food & beverage$1,365100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Route 92 Medical, Inc.2$488
Medtronic3$301
Johnson & Johnson1$248
Penumbra, Inc.1$136
Microtransponder, Inc.1$109
Imperative Care, Inc1$84

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,365 in reported general payments places this provider in the 70th percentile of 418 neurology providers in Washington.

See all neurology providers in Washington

Medicare billing

Part B allowed, 2024
$53,845
Medicare patients
381
Services billed
507

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →